LU75901A1 - - Google Patents
Info
- Publication number
- LU75901A1 LU75901A1 LU75901A LU75901A LU75901A1 LU 75901 A1 LU75901 A1 LU 75901A1 LU 75901 A LU75901 A LU 75901A LU 75901 A LU75901 A LU 75901A LU 75901 A1 LU75901 A1 LU 75901A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/618,176 US4004005A (en) | 1975-09-30 | 1975-09-30 | Steroidal erythropoietic agents and therapeutic compositions and methods |
| US05/693,249 US4049805A (en) | 1975-09-30 | 1976-06-04 | Steroidal erythropoietic agents and therapeutic compositions and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU75901A1 true LU75901A1 (fr) | 1977-05-11 |
Family
ID=27088168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU75901A LU75901A1 (fr) | 1975-09-30 | 1976-09-28 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4049805A (fr) |
| JP (1) | JPS5262263A (fr) |
| CH (1) | CH625253A5 (fr) |
| DE (1) | DE2643936A1 (fr) |
| DK (1) | DK145859C (fr) |
| FR (1) | FR2326198A1 (fr) |
| GB (1) | GB1565229A (fr) |
| IE (1) | IE43859B1 (fr) |
| LU (1) | LU75901A1 (fr) |
| NL (1) | NL7610812A (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2330611A1 (fr) | 1998-05-22 | 1999-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Molecules bifonctionnelles et therapies basees sur celles-ci |
| US20050020524A1 (en) * | 1999-04-15 | 2005-01-27 | Monash University | Hematopoietic stem cell gene therapy |
| US20040241842A1 (en) * | 1999-04-15 | 2004-12-02 | Monash University | Stimulation of thymus for vaccination development |
| US20040258672A1 (en) * | 1999-04-15 | 2004-12-23 | Monash University | Graft acceptance through manipulation of thymic regeneration |
| US20040259803A1 (en) * | 1999-04-15 | 2004-12-23 | Monash University | Disease prevention by reactivation of the thymus |
| AUPR074500A0 (en) * | 2000-10-13 | 2000-11-09 | Monash University | Treatment of t cell disorders |
| US20050042679A1 (en) * | 1999-04-15 | 2005-02-24 | Monash University | Diagnostic indicator of thymic function |
| US20040265285A1 (en) * | 1999-04-15 | 2004-12-30 | Monash University | Normalization of defective T cell responsiveness through manipulation of thymic regeneration |
| NZ525830A (en) * | 2000-10-13 | 2005-07-29 | Norwood Immunology Ltd | Disease prevention by reactivation of the thymus |
| US20060088512A1 (en) * | 2001-10-15 | 2006-04-27 | Monash University | Treatment of T cell disorders |
| DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
| US20080279812A1 (en) * | 2003-12-05 | 2008-11-13 | Norwood Immunology, Ltd. | Disease Prevention and Vaccination Prior to Thymic Reactivation |
| SI1889198T1 (sl) | 2005-04-28 | 2015-02-27 | Proteus Digital Health, Inc. | Farma-informacijski sistem |
| WO2007035716A2 (fr) | 2005-09-16 | 2007-03-29 | Raptor Pharmaceutical Inc. | Compositions de proteines rap specifiques des proteines contenant du cr, et leurs utilisations |
| WO2010095940A2 (fr) | 2009-02-20 | 2010-08-26 | To-Bbb Holding B.V. | Sustème d'administration de médicament à base de glutathionne |
| NZ596876A (en) | 2009-05-06 | 2014-01-31 | Lab Skin Care Inc | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
-
1976
- 1976-06-04 US US05/693,249 patent/US4049805A/en not_active Expired - Lifetime
- 1976-09-20 IE IE2077/76A patent/IE43859B1/en unknown
- 1976-09-22 GB GB39299/76A patent/GB1565229A/en not_active Expired
- 1976-09-28 LU LU75901A patent/LU75901A1/xx unknown
- 1976-09-29 DE DE19762643936 patent/DE2643936A1/de not_active Withdrawn
- 1976-09-29 CH CH1231476A patent/CH625253A5/de not_active IP Right Cessation
- 1976-09-29 JP JP51117876A patent/JPS5262263A/ja active Pending
- 1976-09-29 DK DK437976A patent/DK145859C/da not_active IP Right Cessation
- 1976-09-30 NL NL7610812A patent/NL7610812A/xx not_active Application Discontinuation
- 1976-09-30 FR FR7629388A patent/FR2326198A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| NL7610812A (nl) | 1977-04-01 |
| FR2326198A1 (fr) | 1977-04-29 |
| US4049805A (en) | 1977-09-20 |
| DK437976A (da) | 1977-03-31 |
| GB1565229A (en) | 1980-04-16 |
| DK145859C (da) | 1983-10-03 |
| CH625253A5 (fr) | 1981-09-15 |
| IE43859L (en) | 1977-03-30 |
| DE2643936A1 (de) | 1977-03-31 |
| JPS5262263A (en) | 1977-05-23 |
| DK145859B (da) | 1983-03-21 |
| IE43859B1 (en) | 1981-06-17 |
| FR2326198B1 (fr) | 1980-10-10 |